Top Markets
Coin of the day
Anthera Pharmaceuticals, Inc. Anthera Pharmaceuticals, Inc.

Anthera Pharmaceuticals, Inc.

ANTH
Ранг среди акций #42276
Anthera Pharmaceuticals, Inc., a biopharmaceutical enterprise, concentrates on... Anthera Pharmaceuticals, Inc., a biopharmaceutical enterprise, concentrates on developing and commercializing therapeutic solutions for conditions with significant unmet medical needs. The company's pipeline includes Sollpura, an investigational non-porcine pancreatic enzyme replacement therapy in Phase III clinical trials for individuals with exocrine pancreatic insufficiency. It is also advancing Blisibimod, currently in Phase II clinical evaluation for B-cell mediated autoimmune diseases, such as immunoglobulin A nephropathy (IgA nephropathy). Anthera holds licensing agreements with Amgen, Inc. and Eli Lilly and Company. Founded in 2004, the company's base of operations is in Houston, Texas.
Цена акции
$0.0001
Последняя синхронизация: 2026-08-11
Рыночная капитализация
$2.62K
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля Anthera Pharmaceuticals, Inc. (ANTH)

Категория

История цены акций Anthera Pharmaceuticals, Inc. (ANTH)
Наивысшая цена закрытия: $0.00 2026-08-01

Наименьшая цена закрытия: $450.76 2010-03-01
История цены акций Anthera Pharmaceuticals, Inc. с 2010 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) 0.00%
2025 -18.71%
2024 -4.67%
2023 0.00%
2022 -15.38%
2021 -99.38%
2020 -48.36%
2019 -0.60%
2018 -97.65%
2017 -88.08%
2016 -65.41%
2015 166.78%
2014 -38.48%
2013 -45.84%
2012 -89.34%
2011 26.69%
2010 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.08K -7.16%
KR